Skip Navigation

Details for High Impact Journal

Maintenance notice: We are currently addressing issues with broken links due to recent major website changes. We apologize for any inconvenience and appreciate your patience. Please contact for assistance.

Superfund Research Program

Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (impact factor: 12.531)


  • Karkare S, Chhipa RR, Anderson J, Liu X, Henry HF, Gasilina A, Nassar N, Roychoudhury J, Clark JP, Kumar A, Pauletti GM, Ghosh PK, Dasgupta B. 2014. Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth. Clin Cancer Res 20(1):199-212. doi:10.1158/1078-0432.CCR-13-0762 PMID:24170547 PMCID:PMC3947304




  • Goldberg Z, Rocke DM, Schwietert C, Berglund SR, Santana A, Jones A, Lehmann J, Stern RL, Lu R, Hartmann Siantar CL. 2006. Human in vivo dose response to controlled, low-dose low LET ionizing radiation exposure. Clin Cancer Res 12(12):3723-3729. PMID:16778099


  • Caruso RP, Levinson B, Melamed J, Wieczorek R, Taneja S, Polsky D, Chang C, Zeleniuch-Jacquotte A, Salnikow K, Yee H, Costa M, Osman I. 2004. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients. Clin Cancer Res 10(1):222-227. PMID:14734473


  • Warren AJ, Mustra DJ, Hamilton JW. 2001. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling. Clin Cancer Res 7(4):1033-1042. PMID:11309355


  • Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JN, Pierre KM, Turpie BW, Hamilton JW. 1997. Suppression of p-glycoprotein expression and multi-drug resistance by DNA crosslinking agents. Clin Cancer Res 3:1339-1346. PMID:9815817
to Top